Neurokinin 3 (NK3) Receptor Modulators for the Treatment of Psychiatric Disorders

E-ISSN： 2212-3954|3|1|1-15

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.3, Iss.1, 2008-01, pp. : 1-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits

By Siuciak Judith McCarthy Sheryl Martin A. Chapin D. Stock J. Nadeau D. Kantesaria S. Bryce-Pritt D. McLean S.

Psychopharmacology, Vol. 194, Iss. 2, 2007-10 ,pp. : 185-195

Springer Publishing Company

Access to resources Recommend Favorite

Neurokinin-3 receptor antagonists

By Giardina G.A. Raveglia L.F.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 307-323

Informa Healthcare

Access to resources Recommend Favorite

[ 3 H][ -Ala 8 ]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK 2 receptor

By Goso C. Astolfi M. Parlani M. Manzini S.

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 239-245

Elsevier

Access to resources Recommend Favorite

Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress

By Dawson Lee A Porter Roderick A

Future Medicinal Chemistry, Vol. 5, Iss. 13, 2013-09 ,pp. : 1525-1546

Future Science

Access to resources Recommend Favorite

Omega-3 Fatty Acids in the Treatment of Psychiatric Disorders

By Peet Malcolm Stokes Caroline

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1051-1059

Adis International

Access to resources Recommend Favorite